Report Detail

Pharma & Healthcare Global IV Solutions Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4735167
  • |
  • 24 August, 2026
  • |
  • Global
  • |
  • 114 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global IV Solutions market size was valued at US$ 14232 million in 2025 and is forecast to a readjusted size of US$ 21823 million by 2032 with a CAGR of 6.3% during review period.
In 2025, the global production of IV solutions reached approximately 1.383 billion liters, with an average global market price of around US$10/L. In the same year, the global total production capacity of IV solutions reached 1.728 billion liters. The industry average gross profit margin of this product reached 31%.IV Solutions refer to sterile liquid preparations administered intravenously directly into the human circulatory system. They are primarily used for replenishing fluids, electrolytes, nutrients, blood volume, and delivering drugs. Products are typically packaged in glass bottles, plastic bottles, or soft bags and must meet sterility, pyrogen-free, particulate matter control, and pharmacopoeia standards. Common products include 0.9% sodium chloride injection, glucose injection, lactated Ringer's solution, compound electrolyte solutions, parenteral nutrition solutions (TPN), amino acid infusions, and fat emulsion infusions, widely used in clinical settings such as emergency care, perioperative care, intensive care, cancer treatment, dialysis, and long-term nutritional support.
The upstream of the IV Solutions industry chain mainly includes active pharmaceutical ingredients (APIs), water for injection, packaging materials, and production equipment; the midstream consists of infusion preparation manufacturers responsible for formulation development, aseptic production, quality control, and registration certification; the downstream encompasses hospitals, clinics, emergency centers, hemodialysis centers, home infusion facilities, and pharmaceutical distributors. With an aging population, increasing chronic diseases, and growing demand for home care, downstream applications are gradually expanding from traditional hospitals to home healthcare and specialized infusion centers.
IV solutions are among the essential medications in the global healthcare system, with strong market demand. Future growth will primarily come from an aging population, an increase in cancer and chronic disease patients, increased surgical volume, growing demand for intensive care, and the widespread adoption of home-based intravenous infusion therapy. Simultaneously, the proportion of high-value-added products such as parenteral nutrition (TPN), fat emulsions, specialized electrolyte formulas, and immunonutritional infusions continues to rise, driving the industry's upgrade from traditional fluid replacement to precision nutritional support and specialized treatment. Improved healthcare infrastructure and hospital expansion in developing countries will also bring new market growth; therefore, the global intravenous infusion solutions market is expected to maintain medium-to-high-speed growth in the coming years.
This report is a detailed and comprehensive analysis for global IV Solutions market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IV Solutions market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
Global IV Solutions market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
Global IV Solutions market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
Global IV Solutions market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (US$/L), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IV Solutions
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IV Solutions market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, B. Braun Melsungen, JW Life Science, Shijiazhuang No.4 Pharmaceutical, CR Double-Crane Pharmaceutical, Sichuan Yuanda Shuyang Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
IV Solutions market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Basic Fluid Replacement Infusion
Electrolyte Balance Infusion
Nutritional Infusion
Special Therapeutic Infusion
Market segment by Packaging Form
Glass Bottle Infusion
PP Plastic Bottle Infusion
Non-PVC Soft Bag Infusion
Market segment by Volume
Small Volume Infusion (<100ml)
Medium Volume Infusion (100-500ml)
Large Volume Infusion (>500ml)
Market segment by Application
Hospitals
Clinics
Other
Major players covered
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
B. Braun Melsungen
JW Life Science
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane Pharmaceutical
Sichuan Yuanda Shuyang Pharmaceutical
Beximco Pharmaceuticals
PT Otsuka Indonesia
Pharma Impex Laboratories
Fuso Pharmaceutical Industries
Dai Han Pharm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IV Solutions product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IV Solutions, with price, sales quantity, revenue, and global market share of IV Solutions from 2021 to 2026.
Chapter 3, the IV Solutions competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IV Solutions breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and IV Solutions market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IV Solutions.
Chapter 14 and 15, to describe IV Solutions sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global IV Solutions Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Basic Fluid Replacement Infusion
    • 1.3.3 Electrolyte Balance Infusion
    • 1.3.4 Nutritional Infusion
    • 1.3.5 Special Therapeutic Infusion
  • 1.4 Market Analysis by Packaging Form
    • 1.4.1 Overview: Global IV Solutions Consumption Value by Packaging Form: 2021 Versus 2025 Versus 2032
    • 1.4.2 Glass Bottle Infusion
    • 1.4.3 PP Plastic Bottle Infusion
    • 1.4.4 Non-PVC Soft Bag Infusion
  • 1.5 Market Analysis by Volume
    • 1.5.1 Overview: Global IV Solutions Consumption Value by Volume: 2021 Versus 2025 Versus 2032
    • 1.5.2 Small Volume Infusion (<100ml)
    • 1.5.3 Medium Volume Infusion (100-500ml)
    • 1.5.4 Large Volume Infusion (>500ml)
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global IV Solutions Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospitals
    • 1.6.3 Clinics
    • 1.6.4 Other
  • 1.7 Global IV Solutions Market Size & Forecast
    • 1.7.1 Global IV Solutions Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global IV Solutions Sales Quantity (2021-2032)
    • 1.7.3 Global IV Solutions Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Baxter
    • 2.1.1 Baxter Details
    • 2.1.2 Baxter Major Business
    • 2.1.3 Baxter IV Solutions Product and Services
    • 2.1.4 Baxter IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Baxter Recent Developments/Updates
  • 2.2 Kelun Group
    • 2.2.1 Kelun Group Details
    • 2.2.2 Kelun Group Major Business
    • 2.2.3 Kelun Group IV Solutions Product and Services
    • 2.2.4 Kelun Group IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Kelun Group Recent Developments/Updates
  • 2.3 Fresenius Kabi
    • 2.3.1 Fresenius Kabi Details
    • 2.3.2 Fresenius Kabi Major Business
    • 2.3.3 Fresenius Kabi IV Solutions Product and Services
    • 2.3.4 Fresenius Kabi IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Fresenius Kabi Recent Developments/Updates
  • 2.4 Otsuka
    • 2.4.1 Otsuka Details
    • 2.4.2 Otsuka Major Business
    • 2.4.3 Otsuka IV Solutions Product and Services
    • 2.4.4 Otsuka IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Otsuka Recent Developments/Updates
  • 2.5 ICU Medical
    • 2.5.1 ICU Medical Details
    • 2.5.2 ICU Medical Major Business
    • 2.5.3 ICU Medical IV Solutions Product and Services
    • 2.5.4 ICU Medical IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 ICU Medical Recent Developments/Updates
  • 2.6 B. Braun Melsungen
    • 2.6.1 B. Braun Melsungen Details
    • 2.6.2 B. Braun Melsungen Major Business
    • 2.6.3 B. Braun Melsungen IV Solutions Product and Services
    • 2.6.4 B. Braun Melsungen IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 B. Braun Melsungen Recent Developments/Updates
  • 2.7 JW Life Science
    • 2.7.1 JW Life Science Details
    • 2.7.2 JW Life Science Major Business
    • 2.7.3 JW Life Science IV Solutions Product and Services
    • 2.7.4 JW Life Science IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 JW Life Science Recent Developments/Updates
  • 2.8 Shijiazhuang No.4 Pharmaceutical
    • 2.8.1 Shijiazhuang No.4 Pharmaceutical Details
    • 2.8.2 Shijiazhuang No.4 Pharmaceutical Major Business
    • 2.8.3 Shijiazhuang No.4 Pharmaceutical IV Solutions Product and Services
    • 2.8.4 Shijiazhuang No.4 Pharmaceutical IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
  • 2.9 CR Double-Crane Pharmaceutical
    • 2.9.1 CR Double-Crane Pharmaceutical Details
    • 2.9.2 CR Double-Crane Pharmaceutical Major Business
    • 2.9.3 CR Double-Crane Pharmaceutical IV Solutions Product and Services
    • 2.9.4 CR Double-Crane Pharmaceutical IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CR Double-Crane Pharmaceutical Recent Developments/Updates
  • 2.10 Sichuan Yuanda Shuyang Pharmaceutical
    • 2.10.1 Sichuan Yuanda Shuyang Pharmaceutical Details
    • 2.10.2 Sichuan Yuanda Shuyang Pharmaceutical Major Business
    • 2.10.3 Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Product and Services
    • 2.10.4 Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
  • 2.11 Beximco Pharmaceuticals
    • 2.11.1 Beximco Pharmaceuticals Details
    • 2.11.2 Beximco Pharmaceuticals Major Business
    • 2.11.3 Beximco Pharmaceuticals IV Solutions Product and Services
    • 2.11.4 Beximco Pharmaceuticals IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Beximco Pharmaceuticals Recent Developments/Updates
  • 2.12 PT Otsuka Indonesia
    • 2.12.1 PT Otsuka Indonesia Details
    • 2.12.2 PT Otsuka Indonesia Major Business
    • 2.12.3 PT Otsuka Indonesia IV Solutions Product and Services
    • 2.12.4 PT Otsuka Indonesia IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 PT Otsuka Indonesia Recent Developments/Updates
  • 2.13 Pharma Impex Laboratories
    • 2.13.1 Pharma Impex Laboratories Details
    • 2.13.2 Pharma Impex Laboratories Major Business
    • 2.13.3 Pharma Impex Laboratories IV Solutions Product and Services
    • 2.13.4 Pharma Impex Laboratories IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Pharma Impex Laboratories Recent Developments/Updates
  • 2.14 Fuso Pharmaceutical Industries
    • 2.14.1 Fuso Pharmaceutical Industries Details
    • 2.14.2 Fuso Pharmaceutical Industries Major Business
    • 2.14.3 Fuso Pharmaceutical Industries IV Solutions Product and Services
    • 2.14.4 Fuso Pharmaceutical Industries IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Fuso Pharmaceutical Industries Recent Developments/Updates
  • 2.15 Dai Han Pharm
    • 2.15.1 Dai Han Pharm Details
    • 2.15.2 Dai Han Pharm Major Business
    • 2.15.3 Dai Han Pharm IV Solutions Product and Services
    • 2.15.4 Dai Han Pharm IV Solutions Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Dai Han Pharm Recent Developments/Updates

3 Competitive Environment: IV Solutions by Manufacturer

  • 3.1 Global IV Solutions Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global IV Solutions Revenue by Manufacturer (2021-2026)
  • 3.3 Global IV Solutions Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of IV Solutions by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 IV Solutions Manufacturer Market Share in 2025
    • 3.4.3 Top 6 IV Solutions Manufacturer Market Share in 2025
  • 3.5 IV Solutions Market: Overall Company Footprint Analysis
    • 3.5.1 IV Solutions Market: Region Footprint
    • 3.5.2 IV Solutions Market: Company Product Type Footprint
    • 3.5.3 IV Solutions Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global IV Solutions Market Size by Region
    • 4.1.1 Global IV Solutions Sales Quantity by Region (2021-2032)
    • 4.1.2 Global IV Solutions Consumption Value by Region (2021-2032)
    • 4.1.3 Global IV Solutions Average Price by Region (2021-2032)
  • 4.2 North America IV Solutions Consumption Value (2021-2032)
  • 4.3 Europe IV Solutions Consumption Value (2021-2032)
  • 4.4 Asia-Pacific IV Solutions Consumption Value (2021-2032)
  • 4.5 South America IV Solutions Consumption Value (2021-2032)
  • 4.6 Middle East & Africa IV Solutions Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global IV Solutions Sales Quantity by Type (2021-2032)
  • 5.2 Global IV Solutions Consumption Value by Type (2021-2032)
  • 5.3 Global IV Solutions Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global IV Solutions Sales Quantity by Application (2021-2032)
  • 6.2 Global IV Solutions Consumption Value by Application (2021-2032)
  • 6.3 Global IV Solutions Average Price by Application (2021-2032)

7 North America

  • 7.1 North America IV Solutions Sales Quantity by Type (2021-2032)
  • 7.2 North America IV Solutions Sales Quantity by Application (2021-2032)
  • 7.3 North America IV Solutions Market Size by Country
    • 7.3.1 North America IV Solutions Sales Quantity by Country (2021-2032)
    • 7.3.2 North America IV Solutions Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe IV Solutions Sales Quantity by Type (2021-2032)
  • 8.2 Europe IV Solutions Sales Quantity by Application (2021-2032)
  • 8.3 Europe IV Solutions Market Size by Country
    • 8.3.1 Europe IV Solutions Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe IV Solutions Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific IV Solutions Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific IV Solutions Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific IV Solutions Market Size by Region
    • 9.3.1 Asia-Pacific IV Solutions Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific IV Solutions Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America IV Solutions Sales Quantity by Type (2021-2032)
  • 10.2 South America IV Solutions Sales Quantity by Application (2021-2032)
  • 10.3 South America IV Solutions Market Size by Country
    • 10.3.1 South America IV Solutions Sales Quantity by Country (2021-2032)
    • 10.3.2 South America IV Solutions Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa IV Solutions Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa IV Solutions Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa IV Solutions Market Size by Country
    • 11.3.1 Middle East & Africa IV Solutions Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa IV Solutions Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 IV Solutions Market Drivers
  • 12.2 IV Solutions Market Restraints
  • 12.3 IV Solutions Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of IV Solutions and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of IV Solutions
  • 13.3 IV Solutions Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 IV Solutions Typical Distributors
  • 14.3 IV Solutions Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on IV Solutions. Industry analysis & Market Report on IV Solutions is a syndicated market report, published as Global IV Solutions Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of IV Solutions market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report